Evidence map›Paper›PMID 29452593›Full record

ReviewJournal of nanobiotechnology2018

A review on biosynthesis of silver nanoparticles and their biocidal properties.

Khwaja Salahuddin Siddiqi, Azamal Husen, Rifaqat A K Rao

Open access · goldAbstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 307 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
307citing papers in PubMed, 3 pooled it
52.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

307 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,288 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Enhanced anticancer efficacy ofMaterials today. Bio · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Biogenic Silver Nanoparticle: In vitro antifungal activity against Sporothrix brasiliensis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Microwave-Assisted Biosynthesis of Silver Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2026
    Article
  18. Article
  19. Review
  20. Article

247 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Khwaja Salahuddin SiddiqiDepartment of Chemistry, Aligarh Muslim University, Aligarh, Uttar Pradesh, 202002, India.
Azamal HusenDepartment of Biology, College of Natural and Computational Sciences, University of Gondar, P.O. Box # 196, Gondar, Ethiopia. adroot92@yahoo.co.in.
Rifaqat A K RaoDepartment of Applied Chemistry, Zakir Husain College of Engineering and Technology, Aligarh Muslim University, Aligarh, Uttar Pradesh, 202002, India.
Aligarh Muslim University · INUniversity of Gondar · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Use of silver and silver salts is as old as human civilization but the fabrication of silver nanoparticles (Ag NPs) has only recently been recognized. They have been specifically used in agriculture and medicine as antibacterial, antifungal and antioxidants. It has been demonstrated that Ag NPs arrest the growth and multiplication of many bacteria such as Bacillus cereus, Staphylococcus aureus, Citrobacter koseri, Salmonella typhii, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Vibrio parahaemolyticus and fungus Candida albicans by binding Ag/Ag

Indexed as

Metal NanoparticlesAnimalsAnti-Bacterial AgentsAntifungal AgentsAntioxidantsBacteriaBacterial InfectionsFungiGreen Chemistry TechnologyHumansMicrobial Sensitivity TestsMycosesNanotechnologyReactive Oxygen SpeciesSilverAnti-Bacterial AgentsAntifungal AgentsAntioxidantsReactive Oxygen SpeciesSilverAntimicrobial activityAntioxidant activityGreen synthesisSilver nanoparticlesToxicity mechanism

Identifiers

PMID29452593
PMCPMC5815253
OpenAlexW2807092944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.